SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma’s arm inks pact with PPL Pharma

24 Apr 2025 Evaluate

Piramal Pharma’s material step-down wholly owned subsidiary -- Piramal Healthcare Inc. (PHI) has entered into a Stock Subscription Agreement and Loan Conversion Agreement with PPL Pharma Inc. (PPL Pharma), another step-down wholly owned subsidiary. 

As part of the deal, PHI will subscribe to 1,903 optionally convertible redeemable preference shares (OCRPS) of face value $100,000 each, aggregating to $190,300,000 (Rs 1,626.49 crore) of PPL Pharma, by payment of cash consideration to the extent of $40,100,000 and by way of conversion of outstanding unsecured loan of $150,200,000 owed by PPL Pharma to PHI as on April 1, 2025 (hereinafter referred to as the Transaction).

The Transaction is expected to be completed within a period of around 6 months approximately. Pursuant to the aforesaid Transaction, there will be no change in the percentage of holding of the Company in PHI and PPL Pharma and both entities would continue to remain wholly owned subsidiaries of the Company.  

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.


Piramal Pharma Share Price

148.75 -0.15 (-0.10%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×